Nu Skin Enterprises (NYSE:NUS) Releases Q4 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its fourth quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.250-0.350 for the period, compared to the consensus earnings per share estimate of 0.330. The company issued revenue guidance of $365.0 million-$400.0 million, compared to the consensus revenue estimate of $392.1 million. Nu Skin Enterprises also updated its FY 2025 guidance to 1.250-1.350 EPS.

Nu Skin Enterprises Stock Down 2.0%

Shares of Nu Skin Enterprises stock traded down $0.23 during trading on Thursday, hitting $10.87. The company’s stock had a trading volume of 523,959 shares, compared to its average volume of 621,872. Nu Skin Enterprises has a 52 week low of $5.32 and a 52 week high of $14.62. The company has a fifty day simple moving average of $11.44 and a two-hundred day simple moving average of $9.41. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.38 and a current ratio of 2.01. The company has a market capitalization of $537.80 million, a PE ratio of 5.41 and a beta of 0.97.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, August 7th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.18. The company had revenue of $386.14 million during the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Equities research analysts predict that Nu Skin Enterprises will post 1.05 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently weighed in on NUS shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Wednesday, October 8th. Wall Street Zen raised Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a research note on Sunday, October 12th. Finally, Zacks Research raised shares of Nu Skin Enterprises to a “hold” rating in a research report on Tuesday, August 12th. Three analysts have rated the stock with a Hold rating, According to MarketBeat.com, Nu Skin Enterprises currently has a consensus rating of “Hold” and a consensus price target of $7.00.

Insider Activity

In related news, EVP Chayce David Clark sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total transaction of $239,400.00. Following the completion of the sale, the executive vice president owned 233,140 shares of the company’s stock, valued at $2,790,685.80. This trade represents a 7.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Laura Nathanson sold 6,489 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $12.22, for a total transaction of $79,295.58. Following the completion of the sale, the director owned 33,149 shares of the company’s stock, valued at approximately $405,080.78. The trade was a 16.37% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 58,926 shares of company stock worth $711,364 in the last quarter. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in NUS. Tower Research Capital LLC TRC increased its position in Nu Skin Enterprises by 107.4% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock valued at $40,000 after buying an additional 2,614 shares in the last quarter. Man Group plc boosted its stake in shares of Nu Skin Enterprises by 209.6% in the second quarter. Man Group plc now owns 247,992 shares of the company’s stock worth $1,981,000 after acquiring an additional 167,902 shares during the period. BNP Paribas Financial Markets grew its stake in Nu Skin Enterprises by 2.7% during the second quarter. BNP Paribas Financial Markets now owns 348,646 shares of the company’s stock valued at $2,786,000 after acquiring an additional 9,052 shares in the last quarter. Bridgeway Capital Management LLC lifted its position in shares of Nu Skin Enterprises by 330.2% in the second quarter. Bridgeway Capital Management LLC now owns 215,124 shares of the company’s stock worth $1,719,000 after buying an additional 165,124 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new position in shares of Nu Skin Enterprises in the 2nd quarter worth $174,000. 82.84% of the stock is owned by hedge funds and other institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.